Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Exatecan is a derivative of camptothecin (Item No. 11694) and DNA topoisomerase I inhibitor (IC50 = 0.975 µg/ml).1 It inhibits cell growth in a panel of 32 breast, colon, stomach, and lung cancer cell lines (GI50s = 0.125-10.4 ng/ml). Exatecan (3.325-50 mg/kg) reduces tumor growth in an SC-6-JCK gastric adenocarcinoma mouse xenograft model. It reduces tumor weight in HCT116, PC-6, and PC12 mouse xenograft models when administered at a dose of 75 mg/kg.2 Exatecan has also been used in the synthesis of cytotoxic payload moieties of antibody-drug conjugates (ADCs).3 Formulations containing exatecan have been used in the treatment of breast, gastric, and gastroesophageal cancers.
WARNING This product is not for human or veterinary use.
1. A new water-
2. DE-
3. Exatecan antibody drug conjugates based on a hydrophilic polysarcosine drug-